[1]
“A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata”, Dermatol Reports, vol. 9, no. 2, Nov. 2017, doi: 10.4081/dr.2017.7399.